• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Assembly Biosciences (NQ: ASMB )

    14.24 -0.80 (-5.32%)
    Streaming Delayed Price Updated: 10:00 AM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 998
    Open 14.24
    Bid (Size) 14.62 (1)
    Ask (Size) 15.13 (1)
    Prev. Close 15.04
    Today's Range 14.24 - 14.24
    52wk Range 7.692 - 20.04
    Shares Outstanding 52,121,309
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Insiders Buying American Software And 2 Other Stocks
    Via Benzinga

    Performance

    YTD
    +42.63%
    +42.63%
    1 Month
    -9.30%
    -9.30%
    3 Month
    +7.72%
    +7.72%
    6 Month
    +39.58%
    +39.58%
    1 Year
    +7.88%
    +7.88%

    More News

    Read More
    Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Announces $12.6 Million in Equity Financings
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024
    Via InvestorPlace
    Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023
    Via InvestorPlace
    Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023
    Via InvestorPlace
    Assembly Biosciences Announces Effective Date of Reverse Stock Split
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Provides Anticipated Development Milestones for 2024
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
    From Assembly Biosciences, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Moves Lower; Bank of America Profit Beats Expectations
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.